You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Pregnancy in MS: Balancing the Risks

  • Authors: Patricia K. Coyle, MD; Bianca Weinstock-Guttman, MD
  • CME / CE Released: 9/18/2018
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 9/18/2019
Start Activity


Target Audience and Goal Statement

This activity is intended for neurologists, primary care physicians, obstetricians and gynecologists, and nurses.

The goal of this activity is to review the impact of pregnancy on multiple sclerosis (MS), conception planning, and the treatment of MS during pregnancy.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the data on the use of disease-modifying therapies (DMTs) in MS during pregnancy
  • Have greater competence related to development of a treatment plan for MS during pregnancy


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Patricia K. Coyle, MD

    Professor and Vice Chair of Clinical Affairs
    Director, MS Comprehensive Care Center
    Stony Brook University Medical Center
    Stony Brook, New York

    Disclosures

    Disclosure: Patricia K. Coyle, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Accordant; Acorda Therapeutics; Bayer HealthCare; Biogen; Celgene Corporation; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Sanofi Genzyme Corporation; Serono; Teva Pharmaceuticals USA
    Received grants for clinical research from: Actelion Pharmaceuticals, Ltd; Genentech, Inc.; MedDay; Novartis Pharmaceuticals Corporation

    Dr Coyle does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Coyle does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelist

  • Bianca Weinstock-Guttman, MD

    Professor of Neurology
    Jacobs School of Medicine & Biomedical Sciences
    Department of Neurology
    University of Buffalo
    Buffalo, New York

    Disclosures

    Disclosure: Bianca Weinstock-Guttman, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Biogen; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Sanofi; Teva Pharmaceuticals USA
    Served as a speaker or a member of a speakers bureau for: Biogen; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Sanofi; Teva Pharmaceuticals USA
    Received grants for clinical research from: Biogen; Novartis Pharmaceuticals Corporation; Sanofi; Serono

    Dr Weinstock-Guttman does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Weinstock-Guttman does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Steering Committee

  • Stephen Krieger, MD

    Associate Professor of Neurology
    Director
    Neurology Residency Program
    Icahn School of Medicine at Mount Sinai
    New York, New York

    Disclosures

    Disclosure: Stephen Krieger, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Acorda Therapeutics; Bayer HealthCare; Biogen; EMD Serono, Inc.; Genentech, Inc.; Genzyme Corporation; Mallinckrodt Pharmaceuticals; MedDay Pharmaceuticals; Novartis Pharmaceuticals Corporation; Teva Pharmaceuticals USA; TG Therapeutics
    Served as a speaker or a member of a speakers bureau for: Biogen; Genentech, Inc.

  • Anne H. Cross, MD

    Professor of Neurology
    Washington University School of Medicine
    St. Louis, Missouri

    Disclosures

    Disclosure: Anne H. Cross, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Biogen; EMD Serono, Inc.; Novartis Pharmaceuticals Corporation; Genentech, Inc.; Genzyme Corporation; Sanofi
    Received grants for clinical research from: Genentech, Inc.

  • Gavin Giovannoni, MBBCh, PhD

    Professor and Chair of Neurology
    Barts and The London School of Medicine and Dentistry
    London, United Kingdom

    Disclosures

    Disclosure: Gavin Giovannoni, MBBCh, PHD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Bayer HealthCare; Biogen; Canbex Therapeutics Ltd.; Eisai Inc.; Elan; Five Prime Therapeutics; Genzyme Corporation; Genentech, Inc.; GlaxoSmithKline; GW Pharma; Ironwood Pharmaceuticals, Inc.; Merck & Co., Inc.; Merck Serono; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Roche Holding AG; Sanofi-Aventis; Synthon; Teva Pharmaceuticals USA; Vertex Pharmaceuticals Incorporated

  • Thomas P. Leist, MD, PhD

    Professor of Neurology
    Thomas Jefferson University
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Thomas P. Leist, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Teva Pharmaceuticals USA; Novartis Pharmaceuticals Corporation; Biogen; Genzyme Corporation; EMD Serono, Inc.; Genentech, Inc.
    Served as a speaker or a member of a speakers bureau for: Teva Pharmaceuticals USA; Novartis Pharmaceuticals Corporation; Biogen
    Received grants for clinical research from: Chugai Pharmaceutical Co.; Alkermes, Inc.; Novartis Pharmaceuticals Corporation; Biogen; Genzyme Corporation; Actelion Pharmaceuticals, Ltd

  • Claire Riley, MD

    Assistant Professor of Neurology
    Medical Director
    Columbia MS Center
    Columbia University Irving Medical Center
    New York, New York

    Disclosures

    Disclosure: Claire Riley, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Celgene Corporation; Teva Pharmaceuticals USA

Editors

  • Catherine Friederich Murray

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Catherine Friederich Murray has disclosed no relevant financial relationships.

  • Lisa Foulke

    Associate Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Disclosure Lisa Foulke has disclosed no relevant financial relationships.

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Pregnancy in MS: Balancing the Risks

Authors: Patricia K. Coyle, MD; Bianca Weinstock-Guttman, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 9/18/2018

Valid for credit through: 9/18/2019

processing....

Educational Impact Challenge

The goal of this activity is to educate neurologists, primary care physicians, obstetricians, and gynecologists about DMT use in pregnant patients with MS.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print